Esculetin was more effective in colon cancer,16 leukemia,64 and endometrial cancer27 through downregulating Bcl‐2, simultaneously increasing Bax, and mitigating PI3K/AKT signaling pathway in liver cancer via reducing drug efflux,17 and prostate cancer.25 The gene discussed is BCL2; the disease is leukemia.